Last reviewed · How we verify
Therapeutic Dose 1 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Therapeutic Dose 1 (Therapeutic Dose 1) — Chiesi Farmaceutici S.p.A..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Therapeutic Dose 1 TARGET | Therapeutic Dose 1 | Chiesi Farmaceutici S.p.A. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Therapeutic Dose 1 CI watch — RSS
- Therapeutic Dose 1 CI watch — Atom
- Therapeutic Dose 1 CI watch — JSON
- Therapeutic Dose 1 alone — RSS
Cite this brief
Drug Landscape (2026). Therapeutic Dose 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/therapeutic-dose-1. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing